Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (5): 858-864. doi: 10.3969/j.issn.1671-167X.2015.05.025

• Article • Previous Articles     Next Articles

Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review

SI Jing-wen1*, WANG Li1*, BA Xiao-jun1, ZHANG Xu1, DONG Ying1,2△, ZHANG Ji-xin1, LI Wen-ting2, LI Ting1   

  1. (Department of Pathology, Peking University First Hospital, Beijing 100034, China; Department of Pathology, Affiliated Tumour Hospital, Xinjiang Medical University, Urumqi 830011, China)
  • Online:2015-10-18 Published:2015-10-18
  • Contact: DONG Ying E-mail:dongying_999@163.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (81360381) and the Natural Science Foundation of Xinjiang Uygur Autonomous Region (201318101-2)

Abstract:

SUMMARYLynch syndrome is an autosomal dominant genetic disease characterized by the early onset of colon cancer, endometrial cancer and other tumors caused by a genetic mutation within DNA mismatch repair (MMR) genes. A small subgroup (approximately 3%-5%) of endometrial cancer and colorectal cancer is related to Lynch syndrome. Identification of these patients in clinical practice will be of great benefit to the relatives and patients themselves. We reported two cases, and reviewed the literature and clinical diagnostic guideline. MMR protein was lost in the tumors. Meanwhile the two cases had different clinicopathological characteristics. Together with the literature, our findings may suggest that the MMR protein expression, associated molecular alterations and clinicopathological features and biological behavior of endometrial cancer and colorectal cancer related to Lynch syndrome are different. Thus the algorithm for detection the patients at highest risk is different. To detect the MMR loss by immunohistochemistry is a practicalscreening method.

Key words: Lynch syndrome, Endometrial neoplasms, Colorectal neoplasms, DNA mismatch repair, Immunohistochemistry

CLC Number: 

  • R730.2
[1] YU Yan-fei,HE Shi-ming,WU Yu-cai,XIONG Sheng-wei,SHEN Qi,LI Yan-yan,YANG Feng,HE Qun,LI Xue-song. Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 640-646.
[2] CHI Yan-ting,ZHANG Yan-ping,ZHANG Qiu-lu,LIU Cui-ling,LI bin-bin. Clinicopathological analysis of mucosa associated lymphoid tissue lymphoma secondary to Sjögren’s syndrome in salivary gland [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 40-45.
[3] Ru MA,Xin-bao LI,Feng-cai YAN,Yu-lin LIN,Yan LI. Clinical evaluation of tumor-stroma ratio in pseudomyxoma peritonei from the appendix [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 240-246.
[4] Xiao-peng ZHANG,Wei-yu ZHANG,Fei HUO,Hao HU,Qi WANG,Ke-xin XU. Outcome of surgical management and pathogenesis of female primary bladder neck obstruction [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1052-1055.
[5] Xu-chu ZHANG,Jian-hua ZHANG,Rong-fu WANG,Yan FAN,Zhan-li FU,Ping YAN,Guang-yu ZHAO,Yan-xia BAI. Diagnostic value of 18F-FDG PET/CT and tumor markers (CEA, CA19-9, CA24-2) in recurrence and metastasis of postoperative colorectal moderately differentiated adenocarcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1071-1077.
[6] Chun-feng ZHANG,Yun LIU,Min LU,Xiao-juan DU. Expression of hUTP14a in non-small cell lung cancer [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 145-150.
[7] Lei LIU,Li-hua WANG,Yu-bo REN,Xiao-song RAO,Shao-min YANG. Clinicopathological analysis of aggressive angiomyxoma of soft tissue in abdomino-pelvic cavity [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1098-1101.
[8] MEI Fang, ZHAO Ting-ting, GAO Fei, ZHENG Jie. A rare pulmonary benign bi-phasic tumor: a case report of pulmonary adenofibroma and literature review [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1076-1080.
[9] LIU Chang, CUI Li-gang, WANG Hong-lei. Renal Ewing’s sarcoma/primitive neuroectodermal tumor: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 919-923.
[10] CHEN Yang, WANG Yan-rong, SHI Yan, DAI Guang-hai. Prognostic value of chemotherapy-induced neutropenia in metastatic colon cancer patients undergoing first-line chemotherapy with FOLFOX [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 669-674.
[11] LIU Yan-xia, YANG Xue-song, FU Wei, YAO Hong-wei. Association of single nucleotide polymorphism rs6983267 with ulcerative colitis and colorectal cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 994-999.
[12] DONG Ying, ZHOU Mei, BA Xiao-jun, SI Jing-wen, LI Wen-ting, WANG Ying, LI Dong, LI Ting. Characteristic and clinical significance of DNA methyltransferase 3B overexpression in endometrial carcinoma [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 788-794.
[13] XI Chen-guang, FAN Yu, YANG Xin-yu, LIU Li-bo, WANG Jing-hua, HU Shuai, LI Yan-yan, HE Qun. Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 598-602.
[14] ZHANG Li-Li, WANG Jian-Liu. Nongenomic effects of estrogen on extracellular signal-regulated kinases through initiating transient calcium flux in endometrial cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 489-493.
[15] GONG Bei, HU Hui-Hui, ZHANG Man. Expression of apolipoprotein A-Ⅰ in eight histological types of renal neoplasms [J]. Journal of Peking University(Health Sciences), 2015, 47(1): 155-159.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .